Pay in 4 interest-free payments of $6.44 Learn more
Ships within 48 hours · Estimated delivery Aug 14 - Aug 19
New Research Links GLP-1 Agonists to NAION A study published in JAMA Ophthalmology on July 3, 2024, found that type 2 diabetes patients prescribed GLP-1 agonists were at an increased risk for developing a rare and debilitating eye condition called NAION
Abbass NJ, Allan KC, Talcott KE, Singh RP
This is one of the most common questions I hear in the office
Slowed Gastric Emptying: The drug slows down the rate at which food leaves your stomach, prolonging that feeling of fullness after meals
Tirzepatide (Zepbound/Mounjaro) is a dual GLP-1/GIP agonist, which explains its edge on weight loss
US$ 21.90
US$ 26.25
US$ 20.65
US$ 20.35
